###### What to Learn from this Article?

Implanting total hip arthroplasty in tuberculous hip osteoarthritis is a safe procedure. However, this requires the early commencement of antituberculous drugs.

Introduction {#sec1-1}
============

Tuberculous coxitis still remains an indication for long-term antituberculous medications associated with surgical treatment. The principal surgical modalities include arthrodesis \[[@ref1]\], resection arthroplasty, and total hip arthroplasty (THA) \[[@ref2], [@ref3]\]. Among all these surgical treatments, only the last confers a satisfactory functional status; but in an immune compromised terrain, it does not just expose to risks of early post-operative infections but also to short-term septic loosening. We have not found studies in the literature reporting the results concerning implantation of THA in human immunodeficiency virus (HIV) positive subjects with tuberculous coxitis. However, we sort for its indications in each infection separately.

The aim of this work is to share our experience and our preliminary results of a THA implanted on a 53-year-old subject with the acquired immunodeficiency syndrome (AIDS) who has been on antiretrovirals (ARV) but having an active tuberculous coxitis.

Case Report {#sec1-2}
===========

The subject was a 53-year-old housewife, who consulted in December 2013 for inflammatory pain in the right hip evolving for 3 months controlled with non-steroidal anti-inflammatory drugs, with a walking distance of about 100 m. The medical history revealed that she is HIV infected and on triple ARV for 1 year, with a CD4 count of 473/ml, the viral load was not documented. Evaluation of the right hip showed flexion/extension of 80/20, abduction/adduction of 40/20, internal rotation/external rotation of 20/15, a trendelenburg gait, and a limb length discrepancy of 3 cm. The muscle power of the gluteus medius was 4/5. There was amyotrophy of the right quadriceps muscle. The Merle d'Aubigne and postel hip score was evaluated to be 9/18. The anterior-posterior view of the pelvic X-ray ([Fig. 1](#F1){ref-type="fig"}) shows joint space narrowing, loss of head sphericity, shortened hip length, with no other signs of coxarthrosis (sclerosis, geodes, osteophytes). These findings coupled with the patient's history of immunosuppression were suggestive of a coxitis, which could be due to tuberculosis (TB) infection. However, an MRI scan was not done because it was unavailable, and the patient could not afford to do it due to financial constraints. The full blood count revealed a hemoglobin level of 13 g/dl, however, the white cell count was 8000 with 45% lymphocytes and 50% neutrophiles. The rest of the laboratory investigation was unremarkable.

![Pelvic X-ray showing narrowed joint space, without the other signs of coxarthrosis.](JOCR-6-28-g001){#F1}

The patient was operated for implantation of a THA via the Hardinge approach. During surgery, an incident was encountered while dislocating the hip to resect the femoral head. There was a cream-white liquid that was oozing out of the hip joint ([Fig. 2](#F2){ref-type="fig"}). A sample was rapidly collected per-operative and sent for urgent bacteriological analysis. The gram coloration was negative, the rest of the liquid was then sent for microbiological, mycobacteriological and histological analyses. The debris from reaming and the femoral head ([Fig. 3](#F3){ref-type="fig"}) were also sent for analysis. The surgery was continued and completed with the implantation of a hybrid THA due to the fragile acetabulum; the stem was uncemented while the acetabulum was cemented ([Fig. 4](#F4){ref-type="fig"}). The anatomopathological findings showed an active TB infection ([Fig. 5](#F5){ref-type="fig"}). At the end of the surgery, the limb length discrepancy was corrected. The wound healing was normal, and rehabilitation commenced 24 h after surgery with isometric contractions of the gluteal and quadriceps muscles in bed. She was then verticalized the second day following surgery and walking was assisted using crutches. The patient thence continued with her ARV the same day of surgery and 10 days triple antibiotics initiated. She had a fixed combination of antituberculous drugs (isoniazid, rifampin, pyrazinamide, and ethambutol) to be taken for 12 months. 3 years after the surgery we have not noticed any relapse of the infection or any loosening.

![Per-operative aspect of the cream white liquid.](JOCR-6-28-g002){#F2}

![Femoral head after resection.](JOCR-6-28-g003){#F3}

![Hybrid total hip arthroplasty, uncemented stem and a cemented acetabulum.](JOCR-6-28-g004){#F4}

![Histology showing a caseous necrosis in the middle and peripheral grannulomtosis with giant cells characteristic of tuberculosis.](JOCR-6-28-g005){#F5}

Discussion {#sec1-3}
==========

This write up reports a case of THA with favorable short-term evolution in a 53-year-old female black African, with a tuberculous coxitis complicating an AIDS condition on triple ARV. To the best of our knowledge, this is the first case reported in contemporary literature. For this reason, and despite the fact that it is the only case, reporting it to the scientific community is a warranty. It should be noted that arthropathy has been found to be among the most common orthopedic pathology in HIV-positive patients \[[@ref4]\] and could be either related to HIV-induced immunodeficiency, or due to side effects of antiviral drugs \[[@ref5]\].

Although bacterial infection rates according to the literature are increased in HIV-infected patients who receive surgical treatment \[[@ref6]\], our patient did not show any post-operative sepsis.

Campbell and Hoffman \[[@ref7]\] found that patients with HIV disease are more susceptible to postoperative complications like delayed wound healing, and worsening of their disease condition, however, our patient did not have any wound complications and healed by primary intention.

Some authors have reported that implantation of prosthetic implants in active TB is controversial for fear of disease reactivation, but recent findings showed that metals could be safely used in tuberculous lesions \[[@ref3], [@ref8]\]. Oztürkmen *et al*. \[[@ref9]\] did not observe any reactivation of disease in his 9 cases after an average follow-up of 5.6 years, all the femoral and acetabular components did not show signs of loosening. After 3 years of follow-up our patient presented with adequate bone ingrowth on X-ray films and no signs of loosening. Similarly, Wang *et al*. \[[@ref3]\] had no case of hip dislocation and loosening. Other authors made similar observations \[[@ref10], [@ref11]\]. We carried out thorough debridement of infected tissues and post-operative antituberculous therapy as recommended by Wang *et al*. \[[@ref3]\] thereby lowering the risk of reactivation.

Many authors have indicated and reported favorable results of THA on tuberculous coxitis \[[@ref3], [@ref10], [@ref12]\], associated with long-term antituberculous drugs. Bahebeck *et al*. \[[@ref13]\] and Harrison *et al* \[[@ref14]\] have also reported favorable results of THA on HIV-positive subjects on condition that they are simultaneously on triple ARV and long-term peri-operative antibiotics. Because of the results obtained in the studies mentioned above, our experience on caseous necrosis, and a per-operative negative gram stain, we therefore decided not to do a Girdlestone resection arthroplasty but implant a THA. The histological findings comforted us as we instituted antituberculous drugs. The short- and medium-term results are satisfactory.

Conclusion {#sec1-4}
==========

While awaiting a series of similar subjects which is difficult to assemble due to the rare nature of this association, THA could be a good surgical option on HIV-infected individuals having TB coxitis on condition that the subject is simultaneously placed on triple antibiotics and antituberculous drugs.
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###### Clinical Message

It is possible to do a THA in active tuberculous coxitis in HIV-infected patients on the condition that the patient receives long-term antituberculous drugs and ARVs.
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